SABBY MANAGEMENT LLC
Q3 2026 Form 13-F

SPICEWOOD, TEXAS
CIK 0001535610 · CRD 162659 · Exempt reporting adviser
Consolidated report · includes 1 manager since Q3 2024
$9.0M Reported Value Total
Exempt Reporting Adviser Discretionary Manager
Private funds (Form ADV)
2 funds · $197.4M gross asset value
Private Equity Fund: $181.5M · Hedge Fund: $15.8M
Source: Form ADV filed 2026-07-08
Reported value
$9.0M
Quarter over quarter
-31.5%
Holdings
14
Top-10 concentration
78.6%

Filing Structure

Reports holdings for

  • Hal Mintz (not a 13F filer in our records) · since Q3 2024 · declared by one filing
  • Mintz Hal · File #028-13502 · Q2 2013 – Q1 2025 · declared by one filing

Key People

Form ADV owners & control persons
Hal David Mintz
PRINCIPAL AND MANAGING MEMBER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC
Robert Alan Grundstein
CHIEF COMPLIANCE OFFICER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 13, 2026
Form 13F-HR
Reported value $9.0M
Positions 14
Change in reported value -91.8%
New positions 7
Exited positions 9
Position turnover 69.6%
Top-10 concentration 78.6%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
14 $9.0M
Q2 2026 13F
Filed Aug 14, 2026
16 $110.5M
Q1 2026 13F
Filed May 15, 2026
22 $45.1M
Q4 2025 13F
Filed Feb 17, 2026
25 $69.5M
Q3 2025 13F
Filed Nov 14, 2025
29 $86.4M
Q2 2025 13F
Filed Aug 14, 2025
33 $55.1M
Q1 2025 13F
Filed May 15, 2025
36 $34.0M
Q4 2024 13F
Filed Feb 14, 2025
16 $76.9M
Q3 2024 13F
Filed Nov 14, 2024
27 $186.4M
Q2 2024 13F
Filed Aug 14, 2024
27 $148.7M
Q1 2024 13F
Filed May 15, 2024
43 $173.3M
Q4 2023 13F
Filed Feb 14, 2024
46 $100.0M
Q3 2023 13F
Filed Nov 14, 2023
66 $136.6M
Q2 2023 13F
Filed Aug 14, 2023
68 $122.2M
Q1 2023 13F
Filed May 15, 2023
72 $114.8M
Q4 2022 13F
Filed Feb 14, 2023
89 $114.0M
Q3 2022 13F
Filed Nov 14, 2022
82 $79.3M
Q2 2022 13F
Filed Aug 15, 2022
75 $147.0M
Q1 2022 13F
Filed May 16, 2022
83 $669.7M
Q4 2021 13F
Filed Feb 14, 2022
103 $687.8M

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 TOYO TOYO CO LTD $2.1M 23.26%
2 SIDU P SIDUS SPACE INC $967.8K 10.73%
3 PN PN SMART ENERGY LTD $737.1K 8.17%
4 YXT YXT COM GROUP HLDG LTD $646.6K 7.17%
5 ZVRA ZEVRA THERAPEUTICS INC $634.6K 7.04%
6 CRVO CERVOMED INC $593.0K 6.58%
7 APVO APTEVO THERAPEUTICS INC $423.5K 4.7%
8 ZVRA P ZEVRA THERAPEUTICS INC $375.8K 4.17%
9 SPY P STATE STR SPDR S&P 500 ETF $332.8K 3.69%
10 NYC P ISHARES $280.6K 3.11%
11 IWM ISHARES $277.9K 3.08%
12 PAVS PARANOVUS ENTERTNMNT TECH LTD $260.6K 2.89%
13 SNES SENESTECH INC $211.9K 2.35%
14 SPY C STATE STR SPDR S&P 500 ETF $205.4K 2.28%
15 CPHI CHINA PHARMA HLDGS INC $202.6K 2.25%
16 CANF CAN FITE BIOFARMA LTD $187.5K 2.08%
17 BCTXL BRIACELL THERAPEUTICS CORP $158.2K 1.75%
18 SIDU SIDUS SPACE INC $155.5K 1.72%
19 TOYO C TOYO CO LTD $107.6K 1.19%
20 REVB REVELATION BIOSCIENCES INC $103.7K 1.15%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Similar Managers

Finding Similar Managers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings